Literature DB >> 2059715

Decline in ischaemic heart disease in Iceland and change in risk factor levels.

N Sigfusson1, H Sigvaldason, L Steingrimsdottir, I I Gudmundsdottir, I Stefansdottir, T Thorsteinsson, G Sigurdsson.   

Abstract

OBJECTIVE: To monitor trends in mortality and morbidity due to ischaemic heart disease and compare these with observed levels of risk factors from population surveys.
DESIGN: Analysis of trends in death rates from ischaemic heart disease in Iceland compared with expected rates computed from population surveys. Risk factor levels together with beta factors obtained from Cox's regression analysis were used to compute expected death rates. Trends in morbidity due to acute myocardial infarction were assessed and secular trends in dietary consumption compared with trends in cholesterol concentrations.
SETTING: Reykjavik, Iceland (total population 250,000; over half the population live in Reykjavik).
SUBJECTS: 12,814 randomly selected residents in the Reykjavik area aged 45-64 (6623 men, 6191 women; 72% and 80% of those invited). MAIN OUTCOME MEASURES: Age adjusted rates of myocardial infarction and deaths from ischaemic heart disease. Expected risk from risk factor levels (smoking, total serum cholesterol concentration, systolic blood pressure) at each unique survey visit.
RESULTS: Mortality from ischaemic heart disease has decreased by 17-18% since 1970. During 1981-6 the myocardial infarction attack rate in men under 75 decreased by 23%. A decrease occurred in the level of all three major risk factors after 1968. The fall in the serum cholesterol concentration coincided with a reduction in consumption of dairy fat and margarine. The calculated reduction in risk for the age group 45-64 was about 35%, which was closely similar to the observed decrease in mortality due to ischaemic heart disease in that age group.
CONCLUSION: The reduction in mortality from ischaemic heart disease was substantially due to a decreased incidence of myocardial infarction and could be attributed largely to the reduction in risk factors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2059715      PMCID: PMC1670095          DOI: 10.1136/bmj.302.6789.1371

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  7 in total

1.  Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study.

Authors:  P A Sytkowski; W B Kannel; R B D'Agostino
Journal:  N Engl J Med       Date:  1990-06-07       Impact factor: 91.245

2.  Trends in cardiovascular risk factors in Australia, 1966-1986: evidence from prevalence surveys.

Authors:  A J Dobson
Journal:  Community Health Stud       Date:  1987

3.  A modified life-table analysis system for cohort studies.

Authors:  R J Waxweiler; J J Beaumont; J A Henry; D P Brown; C F Robinson; G O Ness; J K Wagoner; R A Lemen
Journal:  J Occup Med       Date:  1983-02

4.  An improved automated determination of serum total cholesterol with a single color reagent.

Authors:  W D Block; K J Jarrett; J B Levine
Journal:  Clin Chem       Date:  1966-10       Impact factor: 8.327

5.  Trends in cardiovascular disease mortality in industrialized countries since 1950.

Authors:  K Uemura; Z Pisa
Journal:  World Health Stat Q       Date:  1988

6.  Trends in coronary heart disease mortality and associated risk factors in New Zealand.

Authors:  R Beaglehole; D R Hay; F H Foster; D N Sharpe
Journal:  N Z Med J       Date:  1981-06-10

7.  A comparison of trends of coronary heart disease mortality in Australia, USA and England and Wales with reference to three major risk factors-hypertension, cigarette smoking and diet.

Authors:  T Dwyer; B S Hetzel
Journal:  Int J Epidemiol       Date:  1980-03       Impact factor: 7.196

  7 in total
  18 in total

Review 1.  The case of the missing data.

Authors:  James Le Fanu
Journal:  BMJ       Date:  2002-12-21

Review 2.  The importance of diet and physical activity in the treatment of conditions managed in general practice.

Authors:  P Little; B Margetts
Journal:  Br J Gen Pract       Date:  1996-03       Impact factor: 5.386

3.  Incidence, recurrence, and case fatality rates for myocardial infarction in southwestern France, 1985 to 1993.

Authors:  P Marques-Vidal; J B Ruidavets; J P Cambou; J Ferrières
Journal:  Heart       Date:  2000-08       Impact factor: 5.994

4.  Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994.

Authors:  S Capewell; C E Morrison; J J McMurray
Journal:  Heart       Date:  1999-04       Impact factor: 5.994

5.  Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels.

Authors:  J A Critchley; S Capewell
Journal:  J Epidemiol Community Health       Date:  2003-04       Impact factor: 3.710

6.  Cardiovascular risk determination: discrepancy between total cholesterol evaluation and two compound laboratory indices in Norway.

Authors:  J E Berg; A T Høstmark
Journal:  J Epidemiol Community Health       Date:  1994-08       Impact factor: 3.710

7.  Is the prevalence of coronary heart disease falling in British men?

Authors:  F C Lampe; R W Morris; P H Whincup; M Walker; S Ebrahim; A G Shaper
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

8.  Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006.

Authors:  Thor Aspelund; Vilmundur Gudnason; Bergrun Tinna Magnusdottir; Karl Andersen; Gunnar Sigurdsson; Bolli Thorsson; Laufey Steingrimsdottir; Julia Critchley; Kathleen Bennett; Martin O'Flaherty; Simon Capewell
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

9.  By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

Authors:  M R Law; N J Wald; S G Thompson
Journal:  BMJ       Date:  1994-02-05

10.  Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland.

Authors:  E Vartiainen; P Puska; J Pekkanen; J Tuomilehto; P Jousilahti
Journal:  BMJ       Date:  1994-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.